The changing landscape of ischaemic brain injury mechanisms

Nature

Volumn 399, Issue SUPPL., 1999, Pages

  Lee, Jin Moo ^a   Zipfel, Gregory J ^a   Choi, Dennis W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; 3,3 BIS(3 FLUOROPHENYL) N METHYLPROPYLAMINE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APTIGANEL; BASIC FIBROBLAST GROWTH FACTOR; BMS 205452; CALCIUM; CALCIUM CHANNEL; CASPASE INHIBITOR; CLOMETHIAZOLE; DEXTROMETHORPHAN; DEXTRORPHAN; EBSELEN; ELIPRODIL; FLUNARIZINE; FOSPHENYTOIN SODIUM; GAVESTINEL; GLUTAMATE RECEPTOR ANTAGONIST; GV 150528; IFENPRODIL; LUBELUZOLE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIMODIPINE; POTASSIUM; REMACEMIDE; SOMATOMEDIN; TIRILAZAD; UNCLASSIFIED DRUG; ZINC; [1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; [[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID;

ARTERIAL OXYGEN TENSION; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN INJURY; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CLINICAL TRIAL; CYTOTOXICITY; HOMEOSTASIS; HUMAN; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW;

EID: 0033600277     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/399a007     Document Type: Review

References (100)

1. Goldberg, M. P. Stroke Trials Database, Internet Stroke Center at Washington University (cited 5 April 1999) (http://www.neuro.wustl.edu/stroke) (1997).
2. Meldrum, B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68, 113-122 (1985).
3. Rothman, S. M. & Olney, J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19, 105-111 (1986).
4. Choi, D. W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-469 (1988).
5. Nicholls, D. & Attwell, D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11, 462-468 (1990).
6. Choi, D. W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18, 58-60 (1995).
7. Siesjo, B. K. Historical overview. Calcium, ischemia, and death of brain cells. Ann. NY Acad. Sci. 522, 638-661 (1988).
8. Simon, R. P., Swan, J. H., Griffiths, T. & Meldrum, B. S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226, 850-852 (1984).
9. Wieloch, T. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230, 681-683 (1985).
10. Buchan, A. M. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? Cerebrovasc. Brain Metab. Rev. 2, 1-26 (1990).
11. Albers, G. W., Goldberg, M. P. & Choi, D. W. Do NMDA antagonists prevent neuronal injury? Yes. Arch Neurol 49, 418-420 (1992).
12. +. Proc. Natl Acad. Sci. USA 87, 6445-6449 (1990).
13. Aizenman, E., Lipton, S. A. & Loring, R. H. Selective modulation of NMDA responses by reduction and oxidation. Neuron 2, 1257-1263 (1989).
14. Tong, G., Shepherd, D. & Jahr, C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science 267, 1510-1512 (1995).
15. Zhang, S., Ehlers, M. D., Bernhardt, J. P., Su, C. T. & Huganir, R. L. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron 21, 443-453 (1998).
16. McDonald, J. W. et al. Extracellular acidity potentiates AMPA receptor-mediated cortical neuronal death. J Neurosci 18, 6290-6299 (1998).
17. Hollmann, M. & Heinemann, S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108 (1994).
18. 2+-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20, 464-470 (1997).
19. Ying, H. S. et al. Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainate-induced death. J. Neurosci. 17, 9536-9544 (1997).
20. Sheardown, M. J., Nielsen, E. O., Hansen, A. J., Jacobsen, P. & Honore, T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247, 571-574 (1990).
21. 2+ permeable AMPA/ kainate channels display distinct receptor immunoreactivity and are GABAergic. Neurobiol. Dis. 1, 43-49 (1994).
22. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12, 1281-1289 (1994).
23. Matute, C., Sanchez-Gomez, M. V., Martinez-Millan, L. & Miledi, R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl Acad. Sci. USA 94, 8830-8835 (1997).
24. McDonald, J. W., Althomsons, S. P., Hyrc, K. L., Choi, D. W. & Goldberg, M. P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med. 4, 291-297 (1998).
25. Frederickson, C. J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31, 145-238 (1989).
26. Choi, D. W. & Koh, J. Y. Zinc and brain injury. Annu. Rev. Neurosci. 21, 347-375 (1998).
27. Sloviter, R. S. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation. Brain Res. 330, 150-153 (1985).
28. Weiss, J. H., Hartley, D. M., Koh, J. Y. & Choi, D. W. AMPA receptor activation potentiates zinc neurotoxicity. Neuron 10, 43-49 (1993).
29. Sensi, S. L. et al. Measurement of intracellular free zinc in living cortical neurons: routes of entry. J Neurosci 17, 9554-9564 (1997).
30. Manev, H., Kharlamov, E., Uz, T., Mason, R. P. & Cagnoli, C. M. Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Exp. Neurol. 146, 171-178 (1997).
31. 2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc. Natl Acad. Sci. USA 96, 2414-2419 (1999).
32. Tonder, N., Johansen, F. F., Frederickson, C. J., Zimmer, J. & Diemer, N. H. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci. Lett. 109, 247-252 (1990).
33. Johansen, F. F., Tonder, N., Berg, M., Zimmer, J. & Diemer, N. H. Hypothermia protects somatostatinergic neurons in rat dentate hilus from zinc accumulation and cell death after cerebral ischemia. Mol. Chem. Neuropathol. 18, 161-172 (1993).
34. Sorensen, J. C., Mattsson, B., Andreasen, A. & Johansson, B. B. Rapid disappearance of zinc positive terminals in focal brain ischemia. Brain Res. 812, 265-269 (1998).
35. Wyllie, A. H., Kerr, J. F. R. & Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306 (1980).
36. Gwag, B. J. et al. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 77, 393-401 (1997).
37. Johnson, E. M. Jr & Deckwerth, T. L. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16, 31-46 (1993).
38. Hengartner, M. O. & Horvitz, H. R. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4, 581-586 (1994).
39. Linnik, M. D., Zobrist, R. H. & Hatfield, M. D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24, 2002-2008 (1993).
40. MacManus, J. P., Buchan, A. M., Hill, I. E., Rasquinha, I. & Preston, E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164, 89-92 (1993).
41. van Lookeren Campagne, M. & Gill, R. Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat. Neurosci. Lett. 213, 111-114 (1996).
42. Martin, L. J. et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46, 281-309 (1998).
43. Choi, D. W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6, 667-672 (1996).
44. Merry, D. E. & Korsmeyer, S. J. Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci. 20, 245-267 (1997).
45. Martinou, J. C. et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017-1030 (1994).
46. Linnik, M. D., Zahos, P., Geschwind, M. D. & Federoff, H. J. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26, 1670-1674 (1995).
47. Kitagawa, K. et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 29, 2616-2621 (1998).
48. Xue, D., Shaham, S. & Horvitz, H. R. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev. 10, 1073-1083 (1996).
49. Namura, S. et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659-3668 (1998).
50. Hara, H. et al. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad. Sci. USA 94, 2007-2012 (1997).
51. Chen, J. et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 4914-4928 (1998).
52. Gottron, F. J., Ying, H. S. & Choi, D. W. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell. Neurosci. 9, 159-169 (1997).
53. Rothwell, N., Allan, S. & Toulmond, S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100, 2648-2652 (1997).
54. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162-7166 (1995).
55. Du, C., Hu, R., Csernansky, C. A., Hsu, C. Y. & Choi, D. W. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J. Cereb. Blood Flow Metab. 16, 195-201 (1996).
56. Cheng, Y. et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101, 1992-1999 (1998).
57. McDonald, J. W., Behrens, M. I., Chung, C., Bhattacharyya, T. & Choi, D. W. Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain. Res. 759, 228-232 (1997).
58. Gwag, B. J. et al. Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons. Neuroscience 90, 1339-1348 (1999).
59. Bindokas, V. P. & Miller, R. J. Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons. J. Neurosci. 15, 6999-7011 (1995).
60. McConkey, D. J. & Orrenius, S. The role of calcium in the regulation of apoptosis. J. Leukoc. Biol. 59, 775-783 (1996).
61. 2+ influx. J. Neurobiol. 26, 205-212 (1995).
62. Balazs, R., Jorgensen, O. S. & Hack, N. N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 27, 437-451 (1988).
63. 2+. Proc. Natl Acad. Sci. USA 88, 3892-3896 (1991).
64. Hyrc, K., Handran, S. D., Rothman, S. M. & Goldberg, M. P. Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators. J. Neurosci. 17, 6669-6677 (1997).
65. Lipton, S. A. & Kater, S. B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12, 265-270 (1989).
66. 2+ signaling in CA1 neurons after brief ischemia in gerbils. J. Neurophysiol. 81, 299-306 (1999).
67. Koh, J. Y. & Cotman, C. W. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res. 587, 233-240 (1992).
68. Ikonomidou, C. et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283, 70-74 (1999).
69. Yu, S. P. et al. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 278, 114-117 (1997).
70. + channels. J. Leukoc. Biol. 57, 851-855 (1995).
71. + efflux in the activation of apoptosis. J. Biol. Chem. 272, 32436-32442 (1997).
72. Du, C. et al. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Res. 718, 233-236 (1996).
73. Ma, J., Endres, M. & Moskowitz, M. A. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br. J. Pharmacol. 124, 756-762 (1998).
74. Portera-Cailliau, C., Price, D. L. & Martin, L. J. N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J. Neurochem. 66, 692-700 (1996).
75. Kew, J. N., Trube, G. & Kemp, J. A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol. (Lond.) 497, 761-772 (1996).
76. Ginsberg, M. D., Sternau, L. L., Globus, M. Y., Dietrich, W. D. & Busto, R. Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc. Brain Metab. Rev. 4, 189-225 (1992).
77. Auer, R. N. Calcium channel antagonists in cerebral ischemia: a review. Drugs Dev. 2, 307-317 (1993).
78. 2+-free solutions in rat cortical neurons in vitro. J. Neurochem. 68, 1836-1845 (1997).
79. Irwin, R. P., Lin, S. Z., Long, R. T. & Paul, S. M. N-methyl-D-aspartate induces a rapid, reversible, and calcium-dependent intracellular acidosis in cultured fetal rat hippocampal neurons. J. Neurosci. 14, 1352-1357 (1994).
80. Samdani, A. F., Dawson, T. M. & Dawson, V. L. Nitric oxide synthase in models of focal ischemia. Stroke 28, 1283-1288 (1997).
81. Szabo, C. & Dawson, V. L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19, 287-298 (1998).
82. Markgraf, C. G. et al. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke 29, 152-158 (1998).
83. Zhao, Q., Pahlmark, K., Smith, M. L. & Siesjo, B. K. Delayed treatment with the spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol. Scand. 152, 349-350 (1994).
84. Nagayama, M., Zhang, F. & Iadecola, C. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J. Cereb. Blood Flow Metab. 18, 1107-1113 (1998).
85. 2+-mediated injury in myelinated CNS axons. Brain Res. 644, 197-204 (1994).
86. Ivins, K. J., Bui, E. T. & Cotman, C. W. β-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol. Dis. 5, 365-378 (1998).
87. Mattson, M. P., Keller, J. N. & Begley, J. G. Evidence for synaptic apoptosis. Exp. Neurol. 153, 35-48 (1998).
88. Cotrina, M. L. et al. Astrocytic gap junctions remain open during ischemic conditions. J. Neurosci. 18, 2520-2537 (1998).
89. Becker, K. J. Inflammation and acute stroke. Curr. Opin. Neurol. 11, 45-49 (1998).
90. Zhang, R. L. et al. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44, 1747-1751 (1994).
91. Betz, A. L., Yang, G. Y. & Davidson, B. L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15, 547-551 (1995).
92. Koh, J. Y., Gwag, B. J., Lobner, D. & Choi, D. W. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268, 573-575 (1995).
93. Gwag, B. J. et al. BDNF or IGF-I potentiates free radical-mediated injury in cortical cell cultures. NeuroReport 7, 93-96 (1995).
94. Koketsu, N. et al. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol. 35, 451-457 (1994).
95. Snyder, S. H., Lai, M. M. & Burnett, P. E. Immunophilins in the nervous system. Neuron 21, 283-294 (1998).
96. Endres, M. et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 95, 8880-8885 (1998).
97. Toung, T. J. K., Traystman, R. J. & Hurn, P. D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29, 1666-1670 (1998).
98. Chen, J. & Simon, R. Ischemic tolerance in the brain. Neurology 48, 306-311 (1997).
99. Guillemin, K. & Krasnow, M. A. The hypoxic response: huffing and HIFing. Cell 89, 9-12 (1997).
100. Frerichs, K. U. & Hallenbeck, J. M. Hibernation in ground squirrels induces state and species-specific tolerance to hypoxia and aglycemia: an in vitro study in hippocampal slices. J. Cereb. Blood Flow Metab. 18, 168-175 (1998).